CLINICAL TRIAL: PHASE 3 STUDY OF DIMEBON IN PATIENTS WITH MILD-TO-MODERATE HUNTI

临床试验：DIMEBON 在轻度至中度 HUNTI 患者中的 3 期研究

• 批准号: 8166885
• 负责人: JODY COREY-BLOOM
• 金额: $ 0.64万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-12-01 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8166885
• 关键词: Caregivers; Clinical Trials; Cognition; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Interview; Measures; Patients; Placebos; Research; Research Personnel; Resources; Source; United States National Institutes of Health; base; dimebolin; impression; mental state; phase 3 study

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine the effect of Dimebon as compared to placebo on cognition as measured by the Mini-Mental State Examination (MMSE); and determine the effect of Dimebon as compared to placebo on the primary measure of global function, the Clinician's Interview-Based Impression of Change, plus caregiver input (CIBIC-plus).

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 确定Dimebon与安慰剂相比对认知的影响（通过简易精神状态量表测量） 检查（MMSE）;并确定Dimebon与安慰剂相比对总体功能的主要测量结果的影响，即基于临床医生访谈的变化印象加上护理人员输入（CIBIC-plus）。